Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1001-1010 of 1,339) with videos related to

Pageof 134
Sort By:
Pediatric Blood & Cancer|January 20, 2018
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastomaJudith G Villablanca, Lingyun Ji, Adi Shapira-Lewinson, et al.
Intensive Care Medicine|January 18, 2014
One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndromeChen Yu Wang, Carolyn S Calfee, Devon W Paul, et al.
Critical Care (London, England)|December 15, 2015
Elevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): a prospective observational cohort studyBenjamin E Orwoll, Aaron C Spicer, Matt S Zinter, et al.
Pediatric Blood & Cancer|January 23, 2026
The Price of Survival: Global Inequities in Anti-GD2 Immunotherapy for NeuroblastomaRuzanna Papyan, Julieta Hoveyan, Martin Guscott, et al.
Journal of Cellular Biochemistry|May 9, 2007
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cellsGary E Meyer, Louis Chesler, Dandan Liu, et al.
Cell|February 20, 1999
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosisJ S Munger, X Huang, H Kawakatsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastomaDenah R Taggart, Myo M Han, Alekist Quach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|February 19, 2000
Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancerJ M Challinor, C A Miaskowski, L S Franck, et al.
Cancer|July 27, 1999
The International Neuroblastoma Pathology Classification (the Shimada system)H Shimada, I M Ambros, L P Dehner, et al.
Pageof 134

Showing results (1001-1010 of 1,339) with videos related to

Sort By:
Pageof 134
Pediatric Blood & Cancer|January 20, 2018
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastomaJudith G Villablanca, Lingyun Ji, Adi Shapira-Lewinson, et al.
Intensive Care Medicine|January 18, 2014
One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndromeChen Yu Wang, Carolyn S Calfee, Devon W Paul, et al.
Critical Care (London, England)|December 15, 2015
Elevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): a prospective observational cohort studyBenjamin E Orwoll, Aaron C Spicer, Matt S Zinter, et al.
Pediatric Blood & Cancer|January 23, 2026
The Price of Survival: Global Inequities in Anti-GD2 Immunotherapy for NeuroblastomaRuzanna Papyan, Julieta Hoveyan, Martin Guscott, et al.
Journal of Cellular Biochemistry|May 9, 2007
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cellsGary E Meyer, Louis Chesler, Dandan Liu, et al.
Cell|February 20, 1999
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosisJ S Munger, X Huang, H Kawakatsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastomaDenah R Taggart, Myo M Han, Alekist Quach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|February 19, 2000
Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancerJ M Challinor, C A Miaskowski, L S Franck, et al.
Cancer|July 27, 1999
The International Neuroblastoma Pathology Classification (the Shimada system)H Shimada, I M Ambros, L P Dehner, et al.
Pageof 134